Click to
The Retail & Consumer Index
Keeping Retail Leaders Up to Date with Customer Experience Insights
Get Insights Retail & Consumer Leaders Listen To & Take Action On
Get Insights Retail & Consumer Leaders Listen To & Take Action On
Subscribed
Oops! Something went wrong while submitting the form.
Direct to Consumer
Retail
eCommerce
Luxury
Consumer

Top Healthcare AI Consulting Firms to Work With - August 2026

Introduction

Healthcare AI has moved past the pilot problem into a harder one: governance at scale. Health systems are consolidating dozens of point solutions onto enterprise platforms, and regulators have begun clearing foundation models covering many clinical indications at once rather than single narrow tasks. The question is no longer whether to deploy but how to validate and monitor models across an entire organization, which rewards partners holding clinical and regulatory understanding alongside implementation experience. That is a considerably narrower field than the volume of vendors suggests.

This article compares ten providers: seven consulting and services firms, then three AI platform companies, with each entry stating which it is. It is written for CIOs, Chief Medical Information Officers, and Heads of Data and AI at health systems, payers, and life sciences organizations.

How We Selected These Firms

This ranking is published by G&CO.Health. We evaluated providers on healthcare AI specialization, clinical and regulatory understanding, demonstrated deployment at enterprise scale, data assets or technical depth, and suitability for governed multi-year programs.

The list separates consulting firms from AI platform companies, since both appear in searches for healthcare AI consulting and organizations arrive needing one or the other. Entries one through seven are firms; eight through ten are platforms. We include ourselves at the top because healthcare AI sits directly inside our remit, at the intersection of strategy, customer experience, and digital transformation for enterprise healthcare organizations. No provider on this list has paid for placement, and no entry on this page is sponsored.

Firms Compared

The table below summarises where each provider fits. The first seven are consulting and services firms; the last three are AI platform companies.

The Firms

1. G&CO. Health

Best for: Enterprise healthcare organizations where an AI programme has to change a clinical, operational, or commercial outcome, and where adoption depends on how the tool is experienced by the people using it.

Why it stands out: G&CO. Health works on AI mandates where the model is the smaller part of the problem and the workflow around it is the larger one. Capability spans healthcare consulting and UX and interface design, through G&CO. Health. Clinical AI most often fails on adoption rather than accuracy, and designing the point of use alongside the model is what separates a validated tool from a used one. G&CO. Health is part of G&CO., a minority business enterprise (MBE), as certified by the National Minority Supplier Development Council (NMSDC).

May not be best if: You need algorithm development, regulatory submission support for a device, or a deployed clinical AI product.

2. IQVIA

Best for: Global pharmaceutical organizations and large health systems building AI programmes on substantial data assets.

Why it stands out: IQVIA combines consulting, data, and technology at a scale few can match, anchored on longitudinal data covering more than a billion patients. In January 2026 it announced a collaboration with NVIDIA's AI Foundry to build models, agents, and workflows for healthcare and life sciences clients. Where the constraint on an AI programme is data breadth rather than technical capability, that asset is the reason to engage it.

May not be best if: Your programme is focused and clinical, or you need a small senior team rather than enterprise capacity.

3. ZS Associates

Best for: Life sciences commercial organizations connecting AI directly to go-to-market performance.

Why it stands out: ZS is built on analytics and works exclusively in healthcare and life sciences at substantial scale. It has moved clients from predictive models toward agentic systems that take action within commercial workflows rather than producing recommendations for someone else to act on. Where the objective is measurable commercial performance rather than clinical outcome, that orientation is the fit.

May not be best if: Your programme is clinical or operational rather than commercial, where this analytical concentration offers less.

4. CitiusTech

Best for: Payers, providers, and medical technology organizations needing healthcare data engineering underneath the AI.

Why it stands out: CitiusTech is healthcare-focused across technology and consulting, serving payers, providers, and medtech with data engineering, AI consulting, and product development, supported by major cloud partnerships. Most healthcare AI programmes stall on data readiness rather than model quality, and a partner whose core competence is the engineering layer addresses the actual constraint.

May not be best if: You need strategic advisory or clinical validation expertise rather than engineering and delivery.

5. Cognizant

Best for: Large payers and provider organizations deploying AI across operations rather than in a single function.

Why it stands out: Cognizant brings systems integration depth and a substantial healthcare and life sciences practice, applying AI to clinical, administrative, and operational use cases. For enterprise-wide programmes touching claims, care management, and back office simultaneously, the integration capability matters more than specialist AI expertise, because the difficulty is connecting systems rather than building models.

May not be best if: You are running a focused clinical AI deployment where a specialist would move faster at lower cost.

6. Indegene

Best for: Pharmaceutical and biotech commercial teams applying AI across content, data, and healthcare professional engagement.

Why it stands out: Indegene is a digital-first life sciences commercialization company whose platforms orchestrate content, data, and HCP engagement, with growing application of generative AI including medical writing automation. It was named a Leader in ISG's 2026 Provider Lens for life sciences digital commercial operations. For organizations where AI's value sits in the volume of regulated content and interaction, this is the relevant specialisation.

May not be best if: Your programme is clinical, operational, or provider-side rather than pharmaceutical commercial.

7. Tribe AI

Best for: Teams needing senior machine learning expertise quickly without a long procurement cycle.

Why it stands out: Tribe AI operates a network model matching organizations with senior machine learning practitioners who build custom models for diagnostics, patient insight, and predictive analytics. The advantage is speed and seniority without a firm-scale commitment, which suits digital health companies and enterprise teams that hold product direction internally and need capability rather than advice.

May not be best if: You need governance frameworks, regulatory strategy, or a partner accountable for an enterprise programme.

8. Aidoc

Best for: Health systems deploying clinical AI across imaging and acute care. Platform company, not a consultancy.

Why it stands out: Aidoc's foundation model and enterprise platform embed AI across imaging and acute care workflows, deployed in a large number of hospitals internationally. In early 2026 it received a notable clearance for a single foundation model covering multiple acute indications, and a substantial funding round in April 2026 is supporting its move from triage toward broader clinical workflow automation. For systems consolidating point solutions, a platform covering many indications changes the governance burden considerably.

May not be best if: You need strategy, data engineering, or AI outside imaging and acute care.

9. Tempus AI

Best for: Oncology and cardiology programmes requiring linked clinical and molecular data. Platform company.

Why it stands out: Tempus combines clinical and molecular data to support precision medicine, with bioinformatics and real-world evidence capability alongside. For data-rich precision medicine use cases, the linkage between molecular results and clinical outcome is the asset, and building it independently is prohibitive for most organizations.

May not be best if: Your use case is operational or administrative, or sits outside the therapeutic areas the data covers.

10. Savana

Best for: Research institutions and pharmaceutical organizations extracting evidence from clinical text. Platform company.

Why it stands out: Savana specialises in clinical natural language processing, converting unstructured records into real-world evidence and predictive insight while maintaining privacy and compliance. A large share of clinically meaningful information sits in free text rather than structured fields, and organizations that have exhausted their structured data frequently find the remaining value here.

May not be best if: Your priority is workflow automation, imaging, or commercial AI rather than evidence from clinical text.

At G&CO.
We Solve
Problems Through Strategy,
Design and Technology.
*Full Name
*Email
*Company
Message
Submit
Thank you for contacting G & Co.
We’ll be in touch shortly.

The Retail & Consumer Index

Keeping Retail Leaders Up to Date with Customer Experience Insights
Subscribed
Oops! Something went wrong while submitting the form.
Direct to Consumer
Retail
eCommerce
Luxury
Consumer
Oops! Something went wrong while submitting the form.
The Retail & Consumer Index
Keeping Retail Leaders Up to Date with Customer Experience Insights
Subscribed
Oops! Something went wrong while submitting the form.
Direct to Consumer
Retail
eCommerce
Luxury
Consumer

What Is Healthcare AI Consulting?

Healthcare AI consulting is advisory and implementation work helping healthcare organizations identify where artificial intelligence can improve clinical, operational, or commercial performance, and then deploy it under the governance the sector requires.

It differs from general AI consulting in one structural way. A model that influences clinical decisions carries regulatory obligations, liability exposure, and validation requirements that a marketing model does not. That changes the shape of the work: substantially more of the effort sits in validation, monitoring, and documentation than in model development, and firms arriving from other sectors consistently misjudge that ratio.

How Does Healthcare AI Consulting Work?

Engagements typically run through assessment of data readiness and use case value, prioritisation, pilot deployment, validation, and scaled rollout with ongoing monitoring. Governance runs alongside all of it rather than following at the end.

Two things distinguish this from general enterprise AI work. Validation is continuous rather than a gate, because model performance drifts as patient populations, documentation practice, and clinical protocols change, and a model validated once is not validated. And adoption is a clinical question: a tool clinicians do not trust will be overridden or ignored regardless of measured accuracy, which is why the interface and the workflow placement matter as much as the model. Programmes that treat adoption as a training problem discover this late.

What Is a Healthcare AI Consulting Firm?

A healthcare AI consulting firm advises and implements artificial intelligence for healthcare organizations, combining clinical and regulatory understanding with data engineering and deployment capability.

The category is frequently confused with healthcare AI platform companies, and the distinction matters commercially. A consulting firm assesses where AI should be applied and builds or integrates accordingly, charging for an engagement. A platform company sells a deployed capability in a defined area, charging by subscription. Platforms deploy faster within their scope and do not address problems outside it. Firms cover any use case and take longer. Buying the wrong one is the most expensive available error in this category.

What Services Do Healthcare AI Consulting Firms Provide?

AI strategy and use case prioritisation

Identifying where AI creates value and sequencing deployment. The prioritisation matters more than the strategy, since most organizations can name more use cases than they can govern.

Data infrastructure and engineering

Building the pipelines and data quality that models depend on. Most healthcare AI programmes stall here rather than at the modelling stage.

Model development and integration

Building custom models or integrating existing ones into clinical and operational systems, where integration is usually the larger effort.

Clinical workflow design

Determining where in a clinician's workflow a model output appears and what action it prompts. The strongest determinant of whether a tool is used.

Validation, monitoring, and drift management

Ongoing performance measurement against changing populations and practice. A continuing obligation rather than a launch activity.

AI governance and regulatory strategy

Frameworks for approving, documenting, and retiring models, including regulatory classification and evidence requirements.

Change management and clinical engagement

Bringing clinicians into deployment decisions. The most commonly cut line and the most common reason tools go unused.

Vendor assessment and platform consolidation

Evaluating point solutions and consolidating onto enterprise platforms, which is where much current enterprise effort is concentrated.

How Long Does a Healthcare AI Engagement Take?

An AI readiness assessment and use case prioritisation typically runs six to ten weeks. A single-use-case pilot through to validated deployment generally runs four to nine months. An enterprise AI programme covering governance, platform consolidation, and multiple deployments runs eighteen months to three years, phased by use case.

Two variables move these ranges more than technical complexity does. Data readiness, since pipelines and quality work frequently take longer than model development. And clinical governance approval, which runs on committee schedules that cannot be accelerated by adding resource. Organizations that begin governance design before selecting use cases consistently move faster overall, even though it feels like a delay at the start.

How Healthcare AI Firms Price Their Work

Fixed fee suits assessments and defined pilots. Time and materials suits development work where scope evolves. Enterprise programmes are usually priced in phases with milestone billing. Platform companies price by subscription, often per facility, per user, or per study processed.

Outcome-based pricing appears in this category and warrants scrutiny. Tying fees to clinical or financial improvement requires agreement on baseline and attribution, and in healthcare both shift for reasons unconnected to the model: case mix changes, protocols update, staffing varies. Where measurement is settled after the fact, the arrangement generates disputes rather than alignment.

The cost most often omitted is ongoing validation and monitoring. A deployed clinical model carries a permanent obligation to demonstrate continued performance, and organizations that budget for deployment alone find that obligation arriving unfunded in year two.

Why Hire a Healthcare AI Consulting Firm?

The strongest reason is regulatory and validation fluency. The requirements around clinical AI are specific, evolving, and unforgiving, and a partner who has taken models through validation and monitoring repeatedly avoids errors that are expensive to discover after deployment.

The second is honest use case assessment. Internal enthusiasm tends to gather around visible applications rather than valuable ones, and an external partner with comparative exposure can say which use cases have produced results elsewhere and which have consistently disappointed.

The third is that the difficult work is unglamorous. Data pipelines, validation frameworks, and monitoring infrastructure are where programmes succeed or fail, and they are consistently under-resourced internally because they are harder to justify than the model itself.

How to Choose the Most Reliable Healthcare AI Partner

Start by establishing whether the need is a firm or a platform. If the use case is well-defined and a proven platform covers it, deployment will be faster and cheaper than building. If the question is which use cases to pursue and how to govern them, a platform cannot answer it.

Then test three things. Deployed clinical AI experience specifically, since research and pilot work is a weaker signal than models running in production under monitoring. How validation and drift are handled after launch, because that obligation is permanent and frequently unpriced. And how clinicians are brought into deployment decisions, since adoption failure is the dominant failure mode and it is decided during the programme rather than after it.

One further question separates the field. Ask which use cases they would advise you not to pursue. A partner with a specific list has seen programmes fail. A partner enthusiastic about all of them has not been close enough to one.

Decision Intelligence

Acumen by G&CO.

Decision Intelligence Platform for Healthcare & Life Sciences

Visit Acumen

15 Questions to Ask Before You Hire

1. Which use cases would you advise us not to pursue?

A partner with a specific list has watched programmes fail. Enthusiasm about all of them signals distance from delivery.

2. Do we need a consulting firm or a platform for this problem?

Platforms deploy faster within scope and cannot address anything outside it. Buying the wrong one is the costliest error here.

3. How many of your models are running in production under monitoring?

Pilots and research are a weaker signal than deployed models subject to ongoing performance obligations.

4. How do you handle validation and model drift after launch?

Performance degrades as populations and practice change. This obligation is permanent and frequently unpriced.

5. How are clinicians brought into deployment decisions, and when?

Adoption failure is the dominant failure mode, and it is determined during the programme rather than after it.

6. What happens when a clinician disagrees with a model output?

The answer reveals whether the design treats clinical judgement as an input or an obstacle.

7. How ready is our data, and what would it take to fix?

Most programmes stall on data rather than modelling. An honest assessment here is worth more than an ambitious roadmap.

8. What is the regulatory classification of what you are proposing?

Clinical decision support and regulated device software carry different obligations. Establish which before building.

9. Which of your last three deployments underperformed, and why?

A specific answer describes a real record. A claim of none describes a sales position.

10. What does ongoing monitoring cost, and who performs it?

Budgeted for deployment alone, this obligation arrives unfunded in year two.

11. How do you avoid encoding existing bias in our historical data?

Models trained on historical care patterns reproduce historical inequities unless this is addressed deliberately.

12. How will this integrate with our EHR and clinical systems?

Integration is usually a larger effort than modelling and is frequently scoped last.

13. If pricing is outcome-based, how are baseline and attribution agreed?

Case mix and protocols shift independently of the model. Settle measurement before signature.

14. What will you need from our clinical, data, and IT teams?

Internal bandwidth is the usual constraint and the most commonly understated line in a proposal.

15. What would make you decline this engagement?

A partner with a clear answer knows where it adds value. No answer means it is describing capacity, not fit.

Why Choose G&CO.

G&CO. Health is the healthcare practice of G&CO., a global strategy and experience partner working with enterprise health systems, payers, and life sciences organizations. On AI mandates we work where the model meets the person using it: use case prioritisation against clinical and commercial value, the workflow and interface design that determines whether a tool is trusted, and the governance that keeps deployment defensible. Clinical AI fails on adoption far more often than on accuracy, and designing the point of use alongside the model is what closes that gap.

We are typically suited to enterprise healthcare organizations deploying AI alongside a customer experience or digital transformation programme, where treating them separately produces a validated tool that clinicians route around. Where the mandate calls for behavioural and market intelligence alongside the AI work, our Acumen decision intelligence platform supports the segmentation and analysis that informs where automation creates value and where it does not.

G&CO. Health is part of G&CO., a minority business enterprise (MBE), as certified by the National Minority Supplier Development Council (NMSDC). If diversity inclusion is part of your supplier process, we may be a strong fit for your enterprise.

Submit an inquiry to G&CO. Health on our contact page or click the blue Contact Us button on the bottom right of your screen.

The Retail & Consumer Index
Keeping Retail Leaders Up to Date with Customer Experience Insights
Subscribed
Oops! Something went wrong while submitting the form.
Direct to Consumer
Retail
eCommerce
Luxury
Consumer

15 Questions to Ask Before You Hire

1. Which use cases would you advise us not to pursue?

A partner with a specific list has watched programmes fail. Enthusiasm about all of them signals distance from delivery.

2. Do we need a consulting firm or a platform for this problem?

Platforms deploy faster within scope and cannot address anything outside it. Buying the wrong one is the costliest error here.

3. How many of your models are running in production under monitoring?

Pilots and research are a weaker signal than deployed models subject to ongoing performance obligations.

4. How do you handle validation and model drift after launch?

Performance degrades as populations and practice change. This obligation is permanent and frequently unpriced.

5. How are clinicians brought into deployment decisions, and when?

Adoption failure is the dominant failure mode, and it is determined during the programme rather than after it.

6. What happens when a clinician disagrees with a model output?

The answer reveals whether the design treats clinical judgement as an input or an obstacle.

7. How ready is our data, and what would it take to fix?

Most programmes stall on data rather than modelling. An honest assessment here is worth more than an ambitious roadmap.

8. What is the regulatory classification of what you are proposing?

Clinical decision support and regulated device software carry different obligations. Establish which before building.

9. Which of your last three deployments underperformed, and why?

A specific answer describes a real record. A claim of none describes a sales position.

10. What does ongoing monitoring cost, and who performs it?

Budgeted for deployment alone, this obligation arrives unfunded in year two.

11. How do you avoid encoding existing bias in our historical data?

Models trained on historical care patterns reproduce historical inequities unless this is addressed deliberately.

12. How will this integrate with our EHR and clinical systems?

Integration is usually a larger effort than modelling and is frequently scoped last.

13. If pricing is outcome-based, how are baseline and attribution agreed?

Case mix and protocols shift independently of the model. Settle measurement before signature.

14. What will you need from our clinical, data, and IT teams?

Internal bandwidth is the usual constraint and the most commonly understated line in a proposal.

15. What would make you decline this engagement?

A partner with a clear answer knows where it adds value. No answer means it is describing capacity, not fit.

Why Choose G&CO.

G&CO. Health is the healthcare practice of G&CO., a global strategy and experience partner working with enterprise health systems, payers, and life sciences organizations. On AI mandates we work where the model meets the person using it: use case prioritisation against clinical and commercial value, the workflow and interface design that determines whether a tool is trusted, and the governance that keeps deployment defensible. Clinical AI fails on adoption far more often than on accuracy, and designing the point of use alongside the model is what closes that gap.

We are typically suited to enterprise healthcare organizations deploying AI alongside a customer experience or digital transformation programme, where treating them separately produces a validated tool that clinicians route around. Where the mandate calls for behavioural and market intelligence alongside the AI work, our Acumen decision intelligence platform supports the segmentation and analysis that informs where automation creates value and where it does not.

G&CO. Health is part of G&CO., a minority business enterprise (MBE), as certified by the National Minority Supplier Development Council (NMSDC). If diversity inclusion is part of your supplier process, we may be a strong fit for your enterprise.

Submit an inquiry to G&CO. Health on our contact page or click the blue Contact Us button on the bottom right of your screen.

More Resources

Ready to unlock growth?
Contact Us